INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 131 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $14,079 | -84.2% | 25,367 | -66.1% | 0.00% | – |
| Q3 2022 | $89,000 | -39.5% | 74,742 | -67.8% | 0.00% | – |
| Q2 2022 | $147,000 | -37.4% | 232,460 | +12.8% | 0.00% | – |
| Q1 2022 | $235,000 | -56.8% | 206,115 | -14.8% | 0.00% | – |
| Q4 2021 | $544,000 | -24.0% | 241,884 | +15.5% | 0.00% | – |
| Q3 2021 | $716,000 | +364.9% | 209,403 | +305.6% | 0.00% | – |
| Q2 2021 | $154,000 | -50.6% | 51,633 | -46.6% | 0.00% | – |
| Q1 2021 | $312,000 | +89.1% | 96,725 | +24.1% | 0.00% | – |
| Q4 2020 | $165,000 | +157.8% | 77,940 | +43.2% | 0.00% | – |
| Q3 2020 | $64,000 | -30.4% | 54,422 | +61.1% | 0.00% | – |
| Q3 2018 | $92,000 | -43.2% | 33,778 | -60.2% | 0.00% | – |
| Q2 2018 | $162,000 | -0.6% | 84,862 | +9.3% | 0.00% | – |
| Q1 2018 | $163,000 | -46.6% | 77,645 | -48.4% | 0.00% | – |
| Q4 2017 | $305,000 | +208.1% | 150,375 | +102.1% | 0.00% | – |
| Q3 2017 | $99,000 | -74.4% | 74,395 | -69.8% | 0.00% | – |
| Q2 2017 | $387,000 | -14.9% | 246,234 | +75.0% | 0.00% | – |
| Q1 2017 | $455,000 | +58.0% | 140,737 | -34.1% | 0.00% | – |
| Q4 2016 | $288,000 | -8.3% | 213,602 | +6.2% | 0.00% | – |
| Q3 2016 | $314,000 | +9.0% | 201,134 | -6.8% | 0.00% | – |
| Q2 2016 | $288,000 | -96.9% | 215,876 | -87.9% | 0.00% | -100.0% |
| Q1 2016 | $9,387,000 | -59.1% | 1,781,245 | -39.1% | 0.00% | -57.1% |
| Q4 2015 | $22,951,000 | -50.1% | 2,923,766 | -46.3% | 0.01% | -53.3% |
| Q3 2015 | $46,022,000 | -24.9% | 5,446,540 | -2.6% | 0.02% | -21.1% |
| Q2 2015 | $61,245,000 | +18.8% | 5,593,175 | +51.7% | 0.02% | +11.8% |
| Q1 2015 | $51,540,000 | -6.0% | 3,686,699 | +13.5% | 0.02% | 0.0% |
| Q4 2014 | $54,846,000 | +20.2% | 3,247,207 | -4.5% | 0.02% | +21.4% |
| Q3 2014 | $45,624,000 | +0.3% | 3,399,626 | -4.8% | 0.01% | -6.7% |
| Q2 2014 | $45,496,000 | -4.4% | 3,571,100 | -10.8% | 0.02% | 0.0% |
| Q1 2014 | $47,583,000 | +2.7% | 4,001,905 | +19.2% | 0.02% | 0.0% |
| Q4 2013 | $46,351,000 | +18.1% | 3,356,396 | +49.1% | 0.02% | +7.1% |
| Q3 2013 | $39,232,000 | +42.0% | 2,250,829 | +31.9% | 0.01% | +40.0% |
| Q2 2013 | $27,636,000 | +49.2% | 1,706,763 | +222.5% | 0.01% | +42.9% |
| Q4 2012 | $18,521,000 | +827.4% | 529,156 | +522.8% | 0.01% | +600.0% |
| Q3 2012 | $1,997,000 | +510.7% | 84,967 | +252.3% | 0.00% | – |
| Q2 2012 | $327,000 | -2.4% | 24,121 | -13.8% | 0.00% | – |
| Q1 2012 | $335,000 | – | 27,991 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,866,108 | $25,408,000 | 4.32% |
| Nine Chapters Capital Management LLC | 91,500 | $296,000 | 0.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,969,225 | $6,361,000 | 0.24% |
| Orbimed Advisors | 3,250,300 | $10,498,000 | 0.12% |
| PINNACLE ASSOCIATES LTD | 1,306,679 | $4,221,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 810,232 | $2,617,000 | 0.07% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 270,417 | $873,000 | 0.06% |
| Rock Springs Capital Management LP | 270,000 | $872,000 | 0.05% |
| ALGERT GLOBAL LLC | 39,876 | $129,000 | 0.04% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 391,671 | $1,265,000 | 0.03% |